Find Academic Supervisors

Professor Maria Craig is a distinguished academic and researcher at the University of New South Wales, Faculty of Medicine & Health, specializing in childhood diabetes research. She holds a prominent position as a Professor with extensive contributions to the field of pediatric endocrinology and diabetes, particularly focusing on type 1 diabetes in children. Professor Craig's educational background includes: MB BS from the University of Melbourne MMedSc(ClinEpid) from the University of Newcastle PhD from the University of Sydney FRACP (Fellow of the Royal Australasian College of Physicians) Professor Craig's research primarily focuses on childhood diabetes, with special emphasis on prediction and prevention of type 1 diabetes. She has a significant interest in the association between viruses and type 1 diabetes, collaborating with the Virology Research Group at Prince of Wales Hospital (POWH). Together with Professor Bill Rawlinson, she leads the viral theme for the multicentre ENDIA study (endia.org.au). As principal investigator for the CoRD trial, she is conducting a world-first phase 1 study using autologous cord blood for prevention of type 1 diabetes in children with islet autoimmunity. Additionally, she serves as principal investigator for the Australasian Diabetes Data Network (ADDN). Her research portfolio also encompasses the epidemiology of various forms of childhood diabetes (type 1, type 2, cystic fibrosis related diabetes and monogenic diabetes) and diabetes complications, in collaboration with Professor Kim Donaghue at the Children's Hospital at Westmead. Professor Craig's extensive publication record, including over 361 journal articles, demonstrates her leadership in advancing our understanding of childhood diabetes. Her recent work shows increasing focus on early detection methods, risk prediction models, technological interventions for diabetes management, and the complex interplay between viral infections and autoimmune diabetes development. She has been instrumental in developing clinical practice guidelines through her role as co-editor of the International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines. Professor Craig has received numerous prestigious awards recognizing her contributions to pediatric endocrinology and diabetes research: Australian Paediatric Endocrine Group Young Investigator's Award (1997) Asia Pacific Paediatric Endocrine Society Clinical Teaching Award (2008) Lifetime Honorary Member, Caring and Living as Neighbours (2013) Australian Diabetes Society Jeff Flack Diabetes Data Award (2019) Australian Paediatric Endocrine Group Norman Wettenhall Award for Research and Innovation (2019) Throughout her career, Professor Craig has demonstrated exceptional leadership in professional societies, having served as former president/treasurer of the Australasian Paediatric Endocrine Group (APEG) and currently as Scientific Convenor of the Asia Pacific Paediatric Endocrine Society Fellows school. Her work with the ENDIA study and Australasian Diabetes Data Network represents significant collaborative research efforts involving multiple institutions across Australia and internationally. Her principal investigator roles for major studies indicate substantial research funding support. Professor Craig leads several important research initiatives including the ENDIA study, the CoRD trial, and the Australasian Diabetes Data Network. These programs involve multidisciplinary teams of researchers, clinicians, and support staff working collaboratively to advance understanding and treatment of childhood diabetes. Her work at the intersection of virology and diabetes represents a unique and innovative approach to understanding the environmental triggers of type 1 diabetes.

• Childhood Diabetes
• Type 1 Diabetes
• Virology and Diabetes
• +4 more

Gabriela Minigo serves as an Honorary Fellow in Global and Tropical Health and Associate Dean - Learning and Teaching within the Faculty of Health. Her academic profile demonstrates active engagement in malaria immunology research with a recent expansion into circadian rhythm and metabolic health investigations. Dr. Minigo completed her PhD at the University of Melbourne (awarded March 31, 2007) and earned a Master of Clinical Epidemiology from the University of Newcastle (awarded December 8, 2017). Her educational background provides a strong foundation in both basic science and clinical epidemiology. Her primary research focuses on immunological responses to malaria, with particular expertise in T follicular helper cells, dendritic cell function, and regulatory T cells in Plasmodium falciparum and Plasmodium vivax infections. Analysis of her research fingerprint reveals significant contributions to Plasmodium falciparum Immunology and Microbiology (100%), Dendritic Cell Immunology and Microbiology (45%), Regulatory T Cell Immunology and Microbiology (38%), and other related fields. In recent years, she has expanded her research to investigate the relationship between photoperiod, circadian rhythm, and metabolic health, as evidenced by her 2024 publications on these topics. Dr. Minigo's scholarly output shows an evolving research trajectory from fundamental malaria immunology toward interdisciplinary investigations connecting circadian biology with metabolic health. Her recent publications (2022-2024) demonstrate continued strong contributions to malaria immunology while incorporating new dimensions related to light exposure, sleep patterns, and glucose control. She has secured research funding for multiple projects including 'Rainmaker start up- Does exposure to artificial light alter circadian rhythm and glucose control in Australian adults? A pilot study' (2023-2026) where she serves as Co-Investigator, and 'Effect of Extended Photoperiod Exposure on Circadian Rhythm and Glucose Control' (2024-present) where she is Principal Investigator. Previously, she contributed as Chief Investigator C to 'Manipulating T follicular helper cells to improve human malaria vaccines' (2020-2023). As Associate Dean for Learning and Teaching, Dr. Minigo holds significant educational leadership responsibilities within the Faculty of Health. She is registered to supervise postgraduate research, indicating her active role in mentoring graduate students in immunology and tropical medicine research.

• Immunology
• Microbiology
• Malaria Research
• +5 more

Professor Jun Huang is a faculty member in the School of Chemical and Biomolecular Engineering at the University of Sydney, where he holds the rank of Professor and is Director of the Laboratory for Catalysis Engineering. He is also a Domain Leader for Materials at the nanoscale at Sydney Nano Institute and a member of several interdisciplinary institutes, including the China Studies Centre and Sydney Institute of Agriculture. His research focuses on catalysis engineering, with an emphasis on developing sustainable processes for renewable fuels, pollutant treatment, and greenhouse gas mitigation. Huang has held prestigious awards such as the Australia Research Council Future Fellowship (2022) and the Sydney Accelerator Fellowship (2018). Education: Huang earned his PhD from the University of Stuttgart (2008) and completed postdoctoral research at Georgia Institute of Technology and ETH Zurich. He joined the University of Sydney in 2010 as a Lecturer, advancing to Senior Lecturer, Associate Professor, and Professor. Research Interests: Huang's work centers on catalyst design for green chemical processes, including biomass conversion to biofuels, wastewater treatment, and CO2 utilization. He emphasizes sustainable manufacturing and environmental impact reduction through innovative catalytic systems. Current Projects: These include catalytic transformation of hydrocarbons/CO2/biomass, nano-catalysts for renewable energy, and advanced NMR spectroscopy for catalysis analysis. Collaborative projects involve anti-cancer therapies and drug pharmacology studies. Awards: Over 15 awards, including the 2021 ACS Sustainable Chemistry & Engineering Lectureship and 2017 Vice-Chancellor’s Research Excellence Award. Teaching: Huang instructs courses such as CHNG2801 (Conservation Processes), CHNG3802 (Industrial Systems), and advanced chemical engineering topics. He supervises PhD/Master students in catalysis and sustainable engineering. Labs/Teams: Leads the Catalysis Engineering Lab and collaborates with Sydney Nano Institute on nanomaterials research.

• Catalysis Engineering
• Green Chemistry
• Biofuels
• +3 more

Dr. Brooke Devlin is a Lecturer in Nutrition and Dietetics at the School of Human Movement and Nutrition Sciences, University of Queensland . She holds advanced qualifications as an Accredited Practising Dietitian (AdvAPD), Advanced Sports Dietitian (AdvSD), and Accredited Exercise Scientist, with a PhD in Sports Nutrition from La Trobe University (2016) and a Graduate Certificate in Higher Education. Her research focuses on diet and exercise interventions for optimizing blood glucose control , metabolic health , and chrono-nutrition , particularly through time-restricted eating protocols. She also investigates sports nutrition , including athletes' nutrition knowledge and public health interventions in community sports. PhD in Sports Nutrition (La Trobe University, 2016) MNUTRDiet (Nutrition and Dietetics) BExSci (Exercise Science) GradCertHigherEd (Graduate Certificate in Higher Education) Dr. Devlin's research spans two primary domains: metabolic health and sports nutrition . In metabolic health, her work explores time-restricted eating for type 2 diabetes prevention and management, evaluating its impact on glycaemic control , lipoprotein profiles , and health-related quality of life . Her chronological articles reveal a focus on nutritional timing , anti-inflammatory diets , and exercise synergy . For sports nutrition, she examines athletes' dietary behaviors , team sport nutrition , and public health strategies to reduce sugar-sweetened beverages in community sports. Her recent publications include 15 articles from 2025 to 2022, covering topics like anti-inflammatory diets for chronic diseases, TREx trials in diabetes management, and chrono-nutrition applications. These works frequently employ randomized controlled trials , systematic reviews , and meta-analyses , with keywords and subfields reflecting metabolic health , time-restricted eating , chronobiology , nutritional epidemiology , exercise physiology , and public health interventions . Dr. Devlin serves as an Associate Advisor for multiple PhD projects, including studies on genetics of sensory nutrition , dietary patterns in diabetes , and pediatric diabetes care optimization . She is currently a Chief Investigator (CI-D) on a NHMRC MRFF project (2021-2024) titled "What or When to eat to reduce the risk of developing type 2 diabetes (WOW)" and an investigator on a Diabetes Australia Research Project (2021-2023) about time-restricted eating in diabetes management. Her affiliations include the Faculty of Health, Medicine and Behavioural Sciences and collaborations with institutions like La Trobe University and the University of Adelaide.

• Nutrition
• Exercise Science
• Blood Glucose Control
• +6 more

Dr. Evelyn Parr is a Senior Research Fellow at the Mary MacKillop Institute for Health Research, Australian Catholic University (ACU), where she conducts translational research in the Exercise and Nutrition Research Program. Her work focuses on the interplay between exercise, nutrition, and metabolic health, particularly in the context of obesity, type 2 diabetes, and body composition. Her educational background includes undergraduate degrees in Physical Education and Science from the University of Otago, New Zealand, followed by a Master’s in Exercise Metabolism and a PhD titled 'Exercise and nutrient interactions: Effects on skeletal muscle and body fat mass,' awarded in 2016 from ACU. Dr. Parr's research centers on time-restricted eating, nutrient timing, and exercise prescription to improve glycemic control and prevent muscle loss, especially in aging and overweight populations. She investigates how manipulating the timing of food intake and physical activity can optimize metabolic outcomes. Her work often involves randomized controlled trials and collaborations with leading institutions like La Trobe University and the University of Adelaide. The recent publication trends highlight a strong focus on time-restricted eating, circadian metabolism, and exercise timing. Her studies integrate nutrition, physiology, and clinical outcomes, contributing to the growing field of chrononutrition and metabolic disease prevention. Best paper of 2020, Exercise and Sports Science Reviews (awarded 2021) International Travel Award, European Association for the Study of Diabetes (EASD) Conference (2019) Australian Postgraduate Award Scholarship (2014–2015) Best student presentation, SESNZ conference (2014) ESPEN Early Career Fellowship (2018–2019) Dr. Parr has secured significant research funding, including an NHMRC Medical Research Future Fund grant for the TREAT study on preventing type 2 diabetes through time-restricted eating. She supervises higher degree research students and collaborates extensively with Prof John Hawley, Dr Brooke Devlin, and A/Prof Leah Brennan. Her editorial roles include Topic Editor for Nutrients and reviewer for top journals such as Diabetologia , Obesity , and Medicine and Science in Sports and Exercise . She is an active member of professional organizations including Exercise and Sports Science Australia (ESSA), ESPEN, EASD, and The Obesity Society, and contributes to grant review panels for Diabetes Australia and NHMRC.

• Exercise Physiology
• Nutrition
• Metabolism
• +7 more

Professor Lisa Wood is the Pro Vice Chancellor of the College of Health, Medicine and Wellbeing at the University of Newcastle. She holds a PhD in Nutrition and Dietetics and has over 20 years of research experience in nutritional biochemistry, focusing on the interplay between diet, inflammation, and respiratory diseases like asthma and cystic fibrosis. Her work bridges nutrition science and respiratory medicine, emphasizing dietary guidelines for disease management. She leads the Nutrition and Metabolism Theme at HMRI and has supervised 22 PhD and 2 Masters students. Education: BSc (Honours) from the University of Sydney, PhD in Nutrition & Dietetics from the University of Newcastle. Professional roles include former Head of the School of Biomedical Sciences and Pharmacy (2020–2025) and interim Pro Vice Chancellor Student Engagement (2023–2024). Leadership in national organizations includes President of the Nutrition Society of Australia (2016–2021) and Chair of Asthma Australia’s Research Advisory Committee. Research Interests: Mechanisms of dietary factors (e.g., antioxidants, fatty acids, soluble fiber) on airway inflammation; obesity-related asthma; translational nutrition interventions. Key contributions include demonstrating that high fruit/vegetable diets reduce asthma exacerbations and identifying saturated fatty acids’ impact on bronchodilator efficacy. Her work informs clinical guidelines, including the Australian Asthma Handbook. Awards: 2022 Nutrition Society of Australia Medal, 2006 NSW Tall Poppy Award, and multiple mid-career recognitions. Over 210 publications (H-index 57/Scopus). Labs/Teams: Leads the Nutrition Research group in the Priority Research Centre for Asthma and Respiratory Diseases at HMRI. Collaborates with bariatric surgeons and clinical trial networks.

• Nutrition
• Respiratory Diseases
• Inflammation
• +7 more

Timothy Jones is a Clinical Professor at the University of Western Australia (UWA) within the UWA Medical School’s Paediatrics department. He specializes in childhood diabetes and related technologies, focusing on insulin-dependent diabetes mellitus, glycemic control, and automated insulin delivery systems. His research addresses challenges in pediatric diabetes management, including transition care, telehealth integration, and psychosocial outcomes. Key research areas include: Advanced hybrid closed-loop therapy for youth with diabetes Impact of digital technologies on diabetes resilience Automated insulin delivery systems (AID) Hypoglycemia awareness and management Recent articles highlight advancements in diabetes management technologies, emphasizing real-world applications and clinical trial outcomes. His work aligns with UN Sustainable Development Goals related to health and well-being. Grants and projects include: Development of an integrated diabetes data management platform Characterization of hypoglycemia awareness evolution Improving clinical outcomes for young people with type 1 diabetes Validation of physical activity assessment methods in diabetes care Awarded the Research Excellence Award 2022 from the Department of Health (Western Australia), his contributions bridge clinical practice, technology, and public health.

• Childhood Diabetes
• Insulin Dependent Diabetes Mellitus
• Pediatric Endocrinology
• +3 more

Scientia Professor Vlado Perkovic serves as the Provost at UNSW Sydney, having previously held the position of Dean of the Faculty of Medicine and Health at the same institution. He is also a Professorial Fellow at The George Institute for Global Health and was formerly a Staff Specialist in Nephrology at the Royal North Shore Hospital. Professor Perkovic completed his undergraduate medical training at The Royal Melbourne Hospital and earned his Doctor of Philosophy from the University of Melbourne. Professor Perkovic is a leading researcher in clinical trials and epidemiology, with a specialized focus on preventing the progression of kidney disease and its complications. His work has significantly influenced clinical practice through major international clinical trials and contributions to Australian and global guidelines in kidney disease, cardiovascular risk assessment, and blood pressure management. His research spans clinical trial methodology, epidemiology of kidney disease, diabetes complications, and implementation of evidence-based medicine. Analysis of his recent publications reveals a strong emphasis on combination therapies for kidney protection, population-level impacts of novel medications like SGLT2 inhibitors, and long-term benefits of cardiovascular and renal protective agents. His work frequently involves large-scale clinical trial data analysis, particularly from the CANVAS Program and CREDENCE trial, which have shaped treatment approaches for patients with diabetes and chronic kidney disease worldwide. Fellow of the Royal Australasian College of Physicians Fellow of the Australian Academy of Health and Medical Sciences Fellow of the American Society of Nephrology Professor Perkovic has secured substantial research funding and has mentored numerous students and early-career researchers in nephrology. His leadership extends beyond research to academic administration and healthcare policy development. As Provost, he plays a key role in shaping the academic direction of UNSW while maintaining active involvement in clinical research that continues to influence global kidney disease management.

• Clinical Trials
• Epidemiology
• Kidney Disease
• +5 more

Andrew Zannettino is the Executive Dean of the Faculty of Health and Medical Sciences at the University of Adelaide. He holds the academic rank of Professor of Experimental Haematology and co-directs the Myeloma Research Laboratory at SAHMRI. His research focuses on multiple myeloma, bone cancer, and mesenchymal stem cell biology, with significant contributions to patents underlying Mesoblast Ltd's regenerative therapies. He has led over AUD $35 million in grants, including NHMRC, ARC, and industry-funded projects. Key achievements include identifying mechanisms of myeloma-associated bone loss, developing novel biomarkers, and pioneering stem cell therapies. He actively collaborates with global institutions and serves on advisory boards for Myeloma Australia and AusHealth Pty Ltd. Education: Advanced qualifications in Haematology and Molecular Biology (details not explicitly provided). Research Interests: Myeloma pathogenesis, stem cell therapeutics, bone microenvironment, and clinical translation. Awards: Over 300 publications, H-index 73, and recognition as a NHMRC Grant Review Panel member. Grants: Extensive funding from NHMRC, Cancer Australia, and industry partners like Novartis and Mesoblast. His leadership roles include chairing research committees and strategic initiatives at the University of Adelaide. Professional activities include global conference presentations and editorial roles in top journals.

• Multiple Myeloma
• Bone Cancer Research
• Stem Cell Biology
• +3 more

Dr. Arianne Sweeting is a Senior Lecturer in Endocrinology at the University of Sydney's Faculty of Medicine and Health and serves as a Staff Specialist Endocrinologist at Royal Prince Alfred Hospital, where she leads the Maternal Metabolic Health service. She is also a member of the Charles Perkins Centre and holds significant leadership roles in diabetes in pregnancy research and clinical practice. Dr. Sweeting earned her MBBS (Hons), BSc in Neuroscience, Graduate Diploma in Public Health Law from Sydney Law School, and PhD from the University of Sydney's Faculty of Medicine and Health. She became a Fellow of the Royal Australasian College of Physicians in 2015 after receiving NHMRC postgraduate and Albert S McKern obstetric research scholarships for her PhD work on risk management in Gestational Diabetes. Her research focuses on metabolic disease in pregnancy, including diabetes, obesity, bariatric surgery, and eating disorders, with particular emphasis on precision medicine diagnostics, nutrition interventions, and risk management to improve health outcomes for women and their babies. She has pioneered work on early gestational diabetes, establishing and leading the Metabolic Health in Pregnancy service. Her recent publications (2024-2025) demonstrate a strong focus on precision medicine applications in gestational diabetes, with numerous high-impact publications in journals like The Lancet, Diabetes Care, and Communications Medicine. Her work spans epidemiology, pathophysiology, clinical trials (particularly the TOBOGM study), and systematic reviews addressing critical gaps in diabetes management during pregnancy. Australian Diabetes Society Skip Martin Fellow (2022) Sydney Medical School Dean's Publication Prize (2016) International Diabetes Federation World Diabetes Congress Travel Grant (2015) NHMRC Postgraduate Scholarship Albert S McKern Obstetric Research Scholarship Dr. Sweeting leads multiple research projects including the TOBOGM international multicentre trial on early detection of gestational diabetes, PREBABE preconception weight loss trial, and systematic reviews on precision medicine diagnostics. She has secured significant grant funding including the Australian Diabetes Society Early Career Fellowship and MRFF funding for the PreBabe study. Her leadership extends to national and international organizations, including past presidency of the Australasian Diabetes in Pregnancy Society (2020-2022) and membership on the International Association for the Diabetes and Pregnancy Study Groups Council.

• Diabetes in Pregnancy
• Gestational Diabetes
• Metabolic Disease in Pregnancy
• +7 more

Lakshini Herat is a Research Fellow at the University of Western Australia (UWA), affiliated with the School of Biomedical Sciences and the Translation Research Laboratory - Dobney Hypertension Centre. She holds a PhD from UWA (2018) and a B.Sc. from Bangalore University (2006). Her research focuses on Sodium Glucose Co-transporter (SGLT) mechanisms in diabetes, particularly diabetic eye, kidney, and heart complications, alongside hypertension and metabolic syndrome. She has secured grants from bodies like the Royal Perth Hospital Research Foundation and Diabetes Research WA. Lakshini has been recognized with 15+ awards, including the 2023 School of Biomedical Sciences Early-Career Research Award. **Education**: PhD, University of Western Australia (2018) B.Sc., Bangalore University (2006) **Research Interests**: Her work explores SGLT family proteins' roles in diabetes complications and hypertension. Key areas include SGLT2 inhibitors' cardiorenal benefits, sympathetic nervous system interactions, and metabolic syndrome pathophysiology. Her studies span preclinical models and clinical correlations, aiming to translate findings into therapeutic strategies. **Grants & Awards**: 6 competitive grants secured since 2020 16+ awards, including Early-Career Researcher Best Presentation (2022) and Rising Stars Award finalist (2021) **Labs & Teams**: Active in the Dobney Hypertension Centre and collaborates with institutions like the Harry Perkins Institute. Her work contributes to UN Sustainable Development Goals related to health and well-being.

• Diabetes
• Hypertension
• Metabolic Syndrome
• +5 more

Kevin Murray is an Associate Professor at the University of Western Australia's School of Population and Global Health, where he serves as Head of the Division of Population Studies and is affiliated with the Cardiovascular Epidemiology Research Centre (CERC). With over 20 years of experience as an applied biostatistician, he has extensive expertise in clinical trials, epidemiological studies, intervention studies, surveys, longitudinal studies, and studies involving linked data. Dr. Murray's research spans multiple disciplines including biostatistics, epidemiology, cardiovascular disease, population health, and medical statistics. His work contributes significantly to the UN Sustainable Development Goals, particularly in health and well-being. His research fingerprint reveals strong focus areas including Cardiovascular Disease (100%), Symptomatic Treatment (90%), Cardiovascular System (78%), Human Milk (77%), and Malignant Pleural Effusion (75%). He employs methodologies in biostatistical methodology, constrained modeling, and big data analysis to address complex health questions across diverse populations. His recent publications demonstrate a focus on cardiovascular epidemiology, nutrition studies, aging research, and biostatistical methodology. Current research examines dietary patterns, hormone levels, cardiovascular disease markers, and aging biomarkers using large cohort studies like the Busselton Healthy Ageing Study and the Australian Imaging, Biomarkers and Lifestyle study. Scientific Awards: The ICD-Syd Dobbin AM Research Grant 2020 Dr. Murray actively supervises students as principal supervisor for 3 PhD students and co-supervisor for 8 students. He currently chairs the Research Committee and serves as a Board Member of the Busselton Population Medical Research Institute. He represents Australasia on the International Biometrics Society council. His grant portfolio includes 16 projects with 4 currently active, funded by organizations including the Medical Research Future Fund, Healthway, and the Stan Perron Charitable Foundation. Research areas include childhood physical activity interventions, osteoarthritis treatment, methoxyflurane safety, and mental health disorders in craniofacial anomalies. He previously served as Director of the University of Western Australia's Centre for Applied Statistics (2009-2016), where he developed research collaborations and mentored biostatisticians. His work continues to advance methodological approaches in biostatistics while addressing critical population health questions through large-scale epidemiological studies.

• Biostatistics
• Epidemiology
• Population Health
• +6 more

Dr. Keely Bebbington is a Clinical Psychologist and Multi-Discipline Adjunct Senior Research Fellow at The University of Western Australia Medical School, where she leads mental health and wellbeing research at the Rio Tinto Children's Diabetes Centre (a JDRF Global Centre of Excellence). She holds a dual affiliation with the UWA Centre for Child Health Research and The Kids Research Institute Australia. Her primary research interests include mental health and psychosocial functioning in youth with Type 1 Diabetes (T1D), anxiety prevention in children with T1D and their families, and reducing the burden of managing chronic conditions. Her methodological expertise includes thematic analysis and semistructured interviewing, with numerous qualitative studies examining parental and youth experiences in diabetes management. Dr. Bebbington's research portfolio shows a clear progression from earlier work on anxiety mechanisms and autism spectrum disorders toward her current focus on psychosocial aspects of diabetes care. Her publications primarily address psychosocial interventions, technology adoption in diabetes management, and family adaptation to chronic illness. JDRF Rebecca Davies Clinical Research Fellowship As an active researcher and clinician, Dr. Bebbington maintains a part-time private practice while leading the JDRF-funded project 'Preventing the onset of anxiety in children with type 1 diabetes: an intergenerational perspective' (2022-2026). Her work contributes to multiple UN Sustainable Development Goals related to health and wellbeing. Her research group focuses on developing and testing interventions to improve mental health outcomes for children with T1D and their families, with particular attention to anxiety prevention and adjustment to chronic illness.

• Mental Health in Children with Type 1 Diabetes
• Anxiety Prevention
• Psychosocial Functioning in Youth with Chronic Conditions
• +6 more

Shona L. Halson is a Professor at the School of Behavioural and Health Sciences , focusing on Exercise Physiology , Sleep and Performance , and Sports Recovery . Her research spans topics like time-restricted eating , mental fatigue in athletes , and compression garments for recovery. 2025 : Published on alcohol’s effects on sleep 2024 : Studied theacrine’s cognitive impacts and water immersion for inflammation Her work often involves collaborations with institutions like Academic Press and Routledge , contributing to books such as Sleep and Sport (2024). She explores how movement behaviors and nutrition affect health across the lifespan. Key themes in her research include: Sleep Monitoring (2019-2024) Recovery Modalities (cold-water immersion, compression garments) Mental Fatigue in elite athletes and coaches Travel and Jet Lag in sports performance Halson’s publications analyze gait characteristics , inertial measurement units , and athlete self-report measures , with recurring co-authors like John Hawley and Louise Burke . Her work emphasizes the integration of sleep hygiene , nutritional strategies , and technology (e.g., WHOOP devices) to enhance athlete recovery and performance, addressing challenges in team sport and individual sports during global events like the Olympic Games and ICC Women’s T20 World Cup .

• Exercise Physiology
• Sports Recovery
• Sleep and Performance
• +4 more

Sophie Broome is a Postdoctoral Research Fellow at the Mary MacKillop Institute for Health Research within the Faculty of Health Sciences. Her research focuses on metabolic health, exercise physiology, and the interplay between nutrition, exercise, and chronic diseases such as Type 2 Diabetes. She investigates mechanisms related to insulin resistance, mitochondrial function, and the effects of antioxidants on muscle recovery and performance. Her research interests center on understanding how dietary interventions, exercise, and mitochondrial-targeted antioxidants influence metabolic health. Key areas include the role of β-catenin in skeletal muscle insulin resistance, the efficacy of time-restricted eating combined with exercise in managing blood glucose levels, and the impact of mitochondria-targeted antioxidants on muscle recovery and athletic performance. Recent studies have explored topics such as lifespan extension in mice via PI3K inhibitors and the lack of effect of antioxidants on muscle soreness post-exercise. Her work often employs randomized controlled trials and animal models to evaluate intervention efficacy. Broome’s publications span journals in diabetes research, aging biology, and exercise physiology, reflecting her interdisciplinary approach to metabolic health and muscle function. She is affiliated with the Mary MacKillop Institute for Health Research and contributes to collaborative projects within the Faculty of Health Sciences.

• Metabolic Health
• Exercise Physiology
• Diabetes Management
• +3 more